| Novartis Pharma Schweiz AG - Revolade 25mg, Pulver zur Herstellung einer oralen Suspension |
| 65936 | | 01 | | Revolade 25mg | | Pulver zur Herstellung einer oralen Suspension | | B02BX05 | | Eltrombopag | | 18.09.2017 | | |
|
| Composition |
| eltrombopagum 25 mg ut eltrombopagum olaminum, mannitolum, sucralosum, xanthani gummi, ad pulverem pro charta. |
| Packungsbestandteile |
| Soluble Powder | | | | | | Active Agent | Dose |
|---|
| Eltrombopagum | 25 mg |
| | | | Inactive agents |
|---|
| Mannitol | | Sucralosum | | Xanthani Gummi |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
